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A short alternative open reading frame named ORF7a has recently been 
discovered within the nucleocapsid gene of the porcine reproductive and respira-
tory syndrome virus (PRRSV) genome. Proteins (7ap) translated from the ORF7a 
of two divergent strains – a type I and a type II – are able to completely reduce the 
motility of nucleic acids at relatively high molar charge ratios in gel retardation 
assays indicating strong dsDNA- and ssRNA-binding capability. Conserved RNA- 
and DNA-binding properties suggest that nucleic acid binding is a functional 
property of the divergent 7aps, and not an arbitrary consequence of their net posi-
tive charge. Sera from Hu7ap-immunised pigs and mice did not react with Hu7ap 
or Hu7ap-GFP; however, antinuclear antibodies were detected in the sera of the 
immunised animals, suggesting an ability of Hu7ap to interact with or mimic 
autoantigenic macromolecules.  
Key words: Porcine reproductive and respiratory syndrome virus, ORF7a, 
7ap proteins, nucleic acid binding features, antinuclear antibodies  
The porcine reproductive and respiratory syndrome virus (PRRSV) be-
longs to the Arteriviridae family of the Nidovirales order. Since its appearance in 
the late 1980s, PRRSV has caused substantial economic losses to the global 
swine industry (Osorio, 2010; Duinhof, 2011; Zhang and Kono, 2012; Holtkamp 
et al., 2013). PRRSV has a high mutation rate, which led to the evolution of two 
major genotypes: type 1 or European, and type 2 or North American (Murtaugh 
et al., 2010). The high genetic diversity of PRRSV hinders efforts to produce 
vaccines that are cross-protective to heterogeneous PRRSV strains (Mateu and 
Diaz, 2008; Balka et al., 2016). The size of the PRRSV genome is around 15,000 
bases that contains eight larger open reading frames (ORFs). A large polyprotein 
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is translated from the first two ORFs by ribosomal frameshift. Proteolytic diges-
tion of the polyprotein resulted in at least 16 non-structural proteins that are in-
volved in the viral RNA replication. The remaining six ORFs encode the struc-
tural proteins. Overlapping with ORF 1a, ORF 2 and ORF 5 three other smaller 
ORFs were identified, from which three accessory proteins are translated by non-
canonical translation mechanisms (Snijder and Meulenberg, 1998; Meulenberg, 
2000; Wu et al., 2001; Firth et al., 2011; Fang et al., 2012; Olasz et al., 2016a).  
In a previous paper we reported the presence of a short alternative open 
reading frame named ORF7a in the genome of various PRRSV strains. ORF7a 
overlaps with the coding region of the N gene (Olasz et al., 2016b). Depending 
on the virus strain, the length of the encoded protein (7ap) is between 36 and 53 
amino acids (aa). 7aps of two divergent PRRSV strains bind strongly to the Fc part 
of different mammalian IgGs. Furthermore, the 7ap of a type 1 strain (Hu7ap) 
inhibits complement fixation in vitro. 
Here we investigate the DNA- and RNA-binding capacity of the 7ap of 
two divergent PRRSV strains, and describe the presence of antinuclear antibod-
ies in sera from Hu7ap-immunised pigs and mice. The potential functional impli-
cations of the findings are discussed. 
 
 
Materials and methods 
Peptide synthesis 
As we reported earlier (Olasz et al., 2016b), the 7aps of a type I (HU-14432/ 
2011) (Hu7ap MTSGTTSPRLNAPSACNRSRRLSIKAQELRRFHPAGRSVFR 
LSLCCRLLIQCA) and a type II (WuH4) (Wu7ap MTSGITLPLVSGNCVCRRS 
RLPSIRVLELVPCQIQGG) strain were synthesised and purified to 95% purity 
by CASLO ApS (Lyngby, Denmark). 
DNA and RNA gel retardation assay 
Nucleic acid probes were selected randomly by accessibility. The RNA 
probe was transcribed from the 14532–14889 fragment of the PRRSV SD01-08 
strain cloned into the pcDNA3 vector. The plasmid was linearised with XbaI, 
and RNA was synthesised by the TranscriptAid T7 High Yield Transcription Kit 
(Thermo Scientific, Waltham, Massachusetts) following the manufacturer’s rec-
ommendation. RNA was DNAse treated and purified with High Pure Viral Nu-
cleic Acid Kit (Roche, Basel, Switzerland). 
The double-stranded DNA sample was prepared from the pIRES-AcGFP1 
plasmid by digestion with PvuII and HindIII. The PRRS3END (GGCAGGAAC 
CATGTGACCGAAATTAAAAAAAAAAAAAAAAAAAAAAAAGGGTCGGC 
ATGGC) oligonucleotide primer was used as single-stranded DNA probe. 
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For the ssDNA-protein assay 7aps were incubated with 200 ng PRR 
S3END in 7 µl 4 mM MgCl2 0.5 TE (pH 8). For the dsDNA-protein assay 7aps 
were incubated with 500 ng digested pIRES-AcGFP1 in 7 µl 4 mM MgCl2 
0.5 TE (pH 8). For the ssRNA-protein assay 7aps were incubated with 1.3 µg 
RNA and 2U RiboLock RNAse Inhibitor (Thermo Scientific, Waltham, Massa-
chusetts) in 8 µl 5 mM Tris-HCl (pH 8). All reaction mixtures were incubated at 
room temperature for 45 min, then 4 µl loading buffer (25 mM Tris-HCl pH 8 
and 25% glycerol) was added, and the samples were loaded onto a 6% non-
denaturing polyacrylamide gel casted by the Ornstein–Davis method (Ornstein 
and Davis, 1964) and run at 110V in Tris-Glycine running buffer. Nucleic acids 
were visualised with GelRed Nucleic Acid Gel Stain (Biotium, Hayward, Cali-
fornia) following the manufacturer’s recommendation. 
Animal immunisation 
Two mice were immunised intramuscularly with a double dose of 0.2 ml 
emulsion containing crashed gel slices with approximately 20 µg HU7ap (70 µl), 
paraffin oil and thiomersal-containing adjuvant (130 µl) (Merial, Lyon, France). 
The two injections were separated by a two-week interval. A similar immunisa-
tion regime was executed with the K1p peptide (MEVYHFQMQIVLPWPAIH 
SGPCPSRRKCCRSPFNLSVW), which is a hypothetical peptide; its coding se-
quence overlaps with that of the M protein in the PRRSV genome. The K1p-
injected mice served as negative controls in this experiment. 
Two 3-month-old pigs were obtained from a PRRSV-free herd. One pig 
was immunised with a double dose of 0.5 ml emulsion containing crashed gel 
slices with approximately 20 µg HU7ap (160 µl), paraffin oil and thiomersal-
containing adjuvant (340 µl) (Merial, Lyon, France). The two injections were 
separated by an interval of 17 days. The other 3-month-old pig was immunised 
with a double dose of 0.5 ml solution containing crashed gel slices with ap-
proximately 20 µg HU7ap (250 µl) and incomplete Freund’s adjuvant (250 µl). 
The two injections were separated by an interval of 17 days. All animals were 
sacrificed three weeks after the second injection. The animal experiments were 
specifically approved by the ethics committee of the Institute for Veterinary 
Medical Research, Centre for Agricultural Research, Hungarian Academy of 
Sciences. The animal experiment permits were issued by the Food Chain Safety 
and Animal Health Directorate of the Budapest and Pest County Agricultural Of-
fice (mouse immunisation permit number: 22.1/1041/3/2010, pig immunisation 
permit number: XIV-I-001/1300-4/2012). 
Expression of the Hu7ap fusion construct in Marc 145 cells 
7ap of the HU-14432/2011 strain was cloned into the p-MeGFPN1 plas-
mid as described earlier (Olasz et al., 2016b). The resulted plasmid expressing 
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the Hu7ap-GFP fusion protein under the control of the CMV promoter was trans-
fected into 24-well plated Marc 145 cells using the Turbofect (Thermo Scientific, 
Waltham, Massachusetts) transfection reagent following the manufacturer’s rec-
ommendation. 
Indirect immunofluorescence (IF)  
After fixing the cells with 300 μl 3% formaldehyde, they were washed 
twice with 1 ml washing buffer [phosphate-buffered saline (PBS) and 0.1% 
Tween 20]. The samples were permeabilised with 200 μl 1% Triton-X (in PBS) 
for 15 min at room temperature. Following two washing steps the fixed cells 
were incubated with 200 μl serially diluted mouse and pig sera from the peptide-
immunised animals in IF buffer (4% horse serum in PBS) for 1 h. The samples 
were washed twice, and 200 μl of secondary antibodies [CF594 goat anti-mouse 
and CF568 goat anti-swine IgGs (Biotium Hayward, California) in 1000-fold di-
lution] and Hoechst 33342 reagent (1 μg/μl) were added. After 1 h incubation 
and two washings, the samples were examined under a Zeiss Axio Observer D1 
inverse fluorescence research microscope. 
 
 
Results 
Nucleic acid binding 
As we reported earlier, efforts to overexpress the Hu7ap in bacterial cells 
were unsuccessful, despite several attempts with two Escherichia coli expression 
systems. The cause of the failure of overexpression was that the Hu7ap protein 
proved to be highly toxic to the bacterial cells (Olasz et al., 2016b). 
The external addition of the synthesised Hu7ap to bacterial culture or to 
eukaryotic cells did not inhibit bacterial or eukaryotic cell growth (data not 
shown). These observations lessened the possibility of membrane perturbation as 
a cause of toxicity, and raised the suspicion that nucleic acid interaction can be 
behind the lethal effect of Hu7ap expression in bacterial cells. 7aps contain sev-
eral arginines and have a net positive charge that is the hallmark of nucleic acid 
binding proteins. DNA- or RNA-binding by the expressed 7ap can interfere with 
normal cellular processes, which might lead to bacterial toxicity. In line with this 
hypothesis, the RNA- and DNA-binding characteristics of two 7aps were inves-
tigated. 
In a gel retardation assay 250 ng Hu7ap was enough to prevent the entry of 
0.5 µg dsDNA into the gel, 5 µg Hu7ap blocked the migration of 1.3 µg ssRNA, 
and 200 ng ssDNA was prevented from running into the gel by 1 µg Hu7ap. 
Similar results were achieved with Wu7ap, though the affinity of the peptides to 
the nucleic acids investigated was somewhat less (8 µg, 1 µg and 10 µg of Wu7ap 
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titrated out 200 ng ssDNA, 0.5 µg dsDNA and 1.3 µg ssRNA, respectively) than 
that of the Hu7ap (Fig. 1). The molar charge ratios (total negative charge of the 
nucleic acids per total positive charge of the peptides in a reaction), where elec-
trophoretic mobility of the nucleic acids is completely reduced (Hu7ap: 3.65 > 
0.5 > 0.34, Wu7ap: 1.5 > 0.37 > 0.07 for dsDNA, ssRNA and ssDNA, respec-
tively) clearly indicate that both 7aps have the highest affinity to dsDNA while 
they bind ssDNA the least. 
Induction of antinuclear antibodies 
To further investigate the role of 7ap in the life cycle of PPRSV we in-
tended to raise antibodies against Hu7ap. Two mice and two pigs were immu-
nised with SDS-PAGE slices containing the peptide. However, no significant dif-
ferences were detected against Hu7ap in ELISA between the sera of Hu7ap-
immunised animals and those of non-immunised animals (data not shown). To 
further investigate the reactivity of the sera they were examined in indirect IF on 
Hu7ap-GFP fusion protein transiently expressing Marc 145 cells. None of the 
immunised animals’ sera reacted with Hu7ap-GFP (data not shown). However, 
antinuclear antibodies (ANA) were detected in the sera of all animals immunised 
with Hu7ap (Fig. 2). The pig immunised with the incomplete Freund’s adjuvant 
developed less ANA than the pig immunised with paraffin oil and thiomersal ad-
juvant as the antinuclear reactivity of the sera (40× versus 200× dilution) indi-
cated it in IF experiments. A high ANA titre was also revealed in both mice 
(200×) immunised with Hu7ap. The emergence of ANA seemed to be specific to 
Hu7ap because mice immunised with K1p by the same method did not develop 
nucleus-reactive antibodies (Fig. 2). 
Interestingly, the sera of the two animal species reacted differently with 
the nucleus of the Marc 145 cells. Mouse sera reacted strongly with the chromo-
somes of mitotic cells indicating the presence of dsDNA-binding antibodies, 
whereas the sera of pigs showed a distinct fine-speckled staining with resting 
cells, and did not react with the chromosomes of dividing cells, which may indi-
cate antibodies against RNA-binding nucleoproteins Ro and La (Buchner et al., 
2014). 
 
Discussion 
The experiments presented here proved that in addition to its IgG binding 
capability (Olasz et al., 2016b), 7ap also has the potential to interact with nucleic 
acids. Several highly positively charged peptides and proteins are unable to bind 
to nucleic acids (Bousarghin et al., 2003), yet the two investigated 7aps relatively 
strongly bind to dsDNA and ssRNA. High sequential divergence and conserved 
RNA- and DNA-binding properties make it highly plausible that nucleic acid 
binding is functional, and it is not just an arbitrary consequence of the net posi-
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tive charge of 7aps. Functionality of the nucleic acid binding is further supported 
by the fact that highly positively charged HPV peptides with significantly lower 
DNA-binding affinity were able to protect DNA from DNase degradation, and 
were sufficient to obtain gene transfer in COS-7 cells (Bousarghin et al., 2003). 
During transient expression 7ap is initially localised in the nucleus, and 
later accumulates in the cytoplasm (Olasz et al., 2016b). This localisation sug-
gests multiple functions for the protein. One of the functions in the nucleus might 
be the perturbation of the normal host mRNA transcription and processing in co-
operation with the viral nucleocapsid protein which is also positively charged 
and present in the nucleus (You et al., 2008). The cytoplasmic form of 7ap can 
interact with cellular RNAs and may influence normal translational processes of 
the host cells for the benefit of the virus. The interaction of 7ap with intracellular 
proteins is also a possibility. It was reported that the similarly short and basic 
HIV-1 Tat protein exerts its regulatory effect through both nucleic acid and pro-
tein interactions (Vitagliano et al., 2011). Immunisation of different species with 
Hu7ap failed to induce detectable antibodies against the protein. However, un-
successful immunisation is not unusual with small viral proteins and peptides 
(Betakova et al., 2000; Celis, 2002; Zádori et al., 2005). More interestingly, de-
spite the species, adjuvant and immunisation regime differences, all of the ani-
mals developed ANAs after immunisation with Hu7ap. These immunisation ex-
periments suggest an ability of Hu7ap to interact with or mimic autoantigenic 
macromolecules and to induce the breakdown of self-tolerance in different ani-
mals. Autoantibodies directed against nuclear proteins during PRRSV infection 
were also reported (Lemke et al., 2004), so it is tempting to speculate that 7ap 
induces, or at least contributes to, this phenomenon. It is shown that several posi-
tively charged viral and bacterial peptides and proteins (Quaratino et al., 1995; 
Wucherpfennig and Strominger, 1995; Hausmann et al., 1999) can mimic se-
quentially unrelated positively charged autoantigens of human proteins (e.g. 
myelin basic protein, proteins of ribonucleoprotein complex Ro/La, C1q) (Rout-
sias and Tzioufas, 2010; Stoyanova et al., 2012; Mameli et al., 2014), and can ac-
tivate autoreactive T and B cell responses (Vaughan et al., 1995; Wucherpfennig 
and Strominger, 1995; Sospedra et al., 2005). However, sometimes, just like in 
the case of nuclear antigens and Hu7ap, cross-reactivity between autoantigens 
and the inducer of the autoantibodies cannot be detected (Vaughan et al., 1995). 
One possible explanation can be that 7ap itself is not immunogenic, but 
binds to DNA or nucleoprotein complexes released during and after injection 
from damaged tissue (mechanical injury- and adjuvant-generated necrosis or in-
flammation-induced apoptosis), and it may interfere with the normal DNA clear-
ance processes mediated by serum amyloid P and C-reactive protein binding 
(Mold et al., 2001). Normally DNA and nucleoproteins are rapidly cleared from 
an injury site, and failure of clearance can lead to DNA or nucleoprotein specific 
B cell activation (Du Clos, 1996; Bickerstaff et al., 1999).  
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In the present paper we revealed two novel biologically relevant character-
istics of the 7ap protein of PRRSV. The protein binds nucleic acid and during 
immunisation it is able to induce ANA. Further investigations are needed to clar-
ify the in vivo significance of these features in the life cycle of PRRSV. 
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